|1.||Godlewski, Grzegorz: 1 article (11/2006)|
|2.||Baranowska, Urszula: 1 article (11/2006)|
|3.||Malinowska, Barbara: 1 article (11/2006)|
|4.||Schlicker, Eberhard: 1 article (11/2006)|
|5.||Kristinsson, J: 1 article (01/2000)|
|6.||Sigvaldason, K: 1 article (01/2000)|
|7.||Snook, C P: 1 article (01/2000)|
01/01/1984 - "We conclude that prenalterol improves exercise tolerance without any significant cardiovascular or other side effects, and produces a clinically relevant and sustained improvement in patients with chronic heart failure. "
01/01/1982 - "Thus, prenalterol produced markedly beneficial enhancement of cardiocirculatory function without untoward effects and may be useful in the management of patients with severe congestive heart failure. "
01/01/1982 - "Our study could demonstrate, even in patients with severe heart failure, a sustained positive inotropic effect of prenalterol leading to an improved left ventricular contractility, relaxation and compliance. "
05/01/1984 - "Prenalterol, a beta1 agonist, was given in a single blind acute intravenous study to seven patients with cardiac failure (New York Heart Association class II and III). "
01/01/1984 - "A dose response study with oral prenalterol in patients with chronic congestive cardiac failure."
11/01/1983 - "Prenalterol induced a significant improvement in the cardiac index, stroke index, ejection fraction and velocity of circumferential fiber shortening, associated with a moderate but significant decrease in peripheral vascular resistance. "
01/01/1983 - "Maximum increases in cardiac output and stroke work index following intravenous prenalterol correlated significantly with maximum increases observed following oral prenalterol on Day 2. Non-invasive evaluation showed no change in echocardiographic left ventricular end-diastolic dimension but a significant reduction in left ventricular end-systolic dimension on Day 30. "
06/01/1984 - "Prenalterol produced an increase in cardiac index (p less than 0.01), mean aortic pressure (p less than 0.02), net work index (p less than 0.01), net/stroke work index (p less than 0.01), pressure rate product (p less than 0.05), and myocardial perfusion gradient (p less than 0.02). "
03/01/1983 - "Prenalterol induced a statistically significant increase in cardiac index (from 2.6 +/- 0.2 to 3.1 +/- 0.3 1/min/m2), with parallel increases in stroke index (from 28 +/- 2 to 34 +/- 2 ml/beat/m2). "
03/01/1981 - "Prenalterol 500 microgram/5 min increased cardiac index (37.5%), heart rate (19%), stroke index (16.2%), mean arterial pressure (26.5%) and dp/dtmax (84.5%) significantly. "
|3.||Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
01/01/1982 - "Infusion of prenalterol effectively improved the haemodynamic function and cardiac metabolism in congestive cardiomyopathy."
04/01/1983 - "The hemodynamic effects of an acute infusion of prenalterol (PN), a new inotropic beta-adrenoceptor agonist, have been evaluated by cardiac catheterization in 10 patients with primary dilated (congestive) cardiomyopathy. "
04/01/1983 - "Prenalterol in primary dilated cardiomyopathy: hemodynamic and angiographic evaluation."
01/01/1982 - "[Circulatory effects of prenalterol (a selective beta-1 agonist) in normal subjects and in patients with primary congestive cardiomyopathy]."
01/01/1982 - "[Circulatory effects of prenalterol (selective beta-1 agonist) in normal subjects and in patients with primary congestive cardiomyopathy]."
06/01/1984 - "Prenalterol was given to twenty five patients with acute myocardial infarction. "
01/01/1982 - "[Hemodynamic effects of a new beta-1 stimulating drug (prenalterol) in acute myocardial infarct in the open-chest pig]."
01/01/1982 - "[Hemodynamic effects of a new beta-1 stimulating drug (prenalterol) in acute myocardial infarct in swine with open thorax]."
01/01/1983 - "The aim of the study was to assess the effect of Prenalterol on cardiovascular beta adrenergic system of 12 coronary artery disease patients with a previous myocardial infarction. "
09/01/1984 - "Effect of prenalterol on contractility, relaxation, and filling phase in coronary artery disease patients with previous myocardial infarction."
09/01/1984 - "Thus, prenalterol improves cardiovascular function at rest and during pacing-induced tachycardia in ischemic LV failure, but at the cost of higher resting myocardial oxygen consumption. "
09/01/1984 - "In contrast, a strong tachycardia, whether accompanied by positive inotropic effects (prenalterol, 20 gig kg-') or not (atrial pacing at 175 beats min-1) induces deleterious effects on RMBF and cardiac function in the ischaemic myocardium."
09/01/1984 - "Thus, a significant increase in contractility, associated with little tachycardia (prenalterol, 5 micrograms kg-1), induces beneficial effects on RMBF and function in both the nonischaemic and ischaemic myocardium. "
09/01/1984 - "During pacing induced tachycardia (121 +/- 4 beats/min), prenalterol improved cardiac index and stroke work index; whereas, LV filling pressure, systemic vascular resistance, and pulmonary artery pressure decreased. "
05/01/1988 - "Prenalterol, 50 mg, increased sleeping heart rate, supine heart rate, systolic blood pressure, forearm blood flow, and finger tremor, decreased diastolic blood pressure, and had no effect on exercise tachycardia. "
|7.||Adrenergic Agonists (Adrenergic Receptor Agonist)
|10.||Pindolol (LB 46)